72.11.Z - Research and experimental development on biotechnology
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
47.75.Z - Retail sale of cosmetic and toilet articles in specialised stores
70.21.Z - Public relations and communication activities
70.22.Z - Business and other management consultancy activities
72.19.Z - Other research and experimental development on natural sciences and engineering
72.20.Z - Research and experimental development on social sciences and humanities
73.20.Z - Market research and public opinion polling
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
2019 | 2020 | 2021 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -25,3 | -26,4 | -96 | -263,9 |
EBITDA | 14,8 | 21,1 | -48,4 | -329,9 |
Short time liabilities | 450,6 | 578,3 | 619,3 | 7,1 |
Equity capital | -411,3 | -437,7 | -533,8 | -21,9 |
Operating profit (EBIT) | -6,5 | 0,5 | -68,9 | -13 262,8 |
Assets | 39,3 | 140,6 | 85,5 | -39,2 |
Net profit (loss) | -25,3 | -26,4 | -96 | -263,9 |
Cash | 16,6 | 56,5 | 20,2 | -64,2 |
Net income from sale | 45,9 | 28,8 | 0 | -100 |
Liabilities and provisions for liabilities | 450,6 | 578,3 | 619,3 | 7,1 |
Working assets | 34 | 57 | 22,4 | -60,7 |
Depreciation | 21,4 | 20,5 | 20,5 | -0,4 |
% | % | % | p.p. | |
Profitability of capital | 6,2 | 6 | 18 | 12 |
Equity capital to total assets | -1046,8 | -311,3 | -624,1 | -312,8 |
Gross profit margin | -55,2 | -91,6 | -36,4 | |
EBITDA Margin | 32,4 | 73,1 | 40,7 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 3587 | 7326 | 2 147 483 648 | 2 147 476 322 |
Current financial liquidity indicator | 0.0986003577709198 | 0.036185309290885925 | -0,1 | |
Net dept to EBITDA | 19.587186813354492 | -9.828463554382324 | -29,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane